4-fluoro-n1-methyl-n1-propylbenzene-1,2-diamine | 1092496-43-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 4-fluoro-n1-methyl-n1-propylbenzene-1,2-diamine
• 英文别名: 4-fluoro-1-N-methyl-1-N-propylbenzene-1,2-diamine
• CAS: 1092496-43-9
• 化学式: C₁₀H₁₅FN₂
• 分子量: 182.241
• InChiKey: UKUWUIFEGWJDMU-UHFFFAOYSA-N

物化性质

• 沸点：
  282.0±30.0 °C(Predicted)
• 密度：
  1.091±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  29.3
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
  申请人：ELI LILLY AND COMPANY LIMITED

  公开号：EP0897921A1

  公开（公告）日：1999-02-24

  Compounds having the formula: in which n is 1 or 2, m is 1 or 2, p is 1 to 6, q is 0 or 1 to 3, R1 and R2 are each hydrogen or C1-4 alkyl, R3, R4 and R5 are each hydrogen, C1-4 alkyl, optionally substituted phenyl or optionally substituted phenyl-C1-4 alkyl, or R3 and R4 together form an alkylene link of formula -(CH2)3- or -(CH2)4-, or R4 and R5 together with the carbon atom to which they are attached form a C3-6 cycloalkyl group, R6 is C1-4 alkyl, C1-4 alkoxy, carboxy, hydroxy, cyano, halo, trifluoromethyl, nitro or amino, the dotted line represents an optional double bond, and the fluorine atom is attached at the 6 or 7-position; and salts and esters thereof, are binding to the 5-HT serotonin receptor and are useful in the treatment of CNS disorders.

  具有以下化学式的化合物： 其中n为1或2，m为1或2， p为1至6，q为0或1至3， R1和R2分别为氢或C1-4烷基， R3、R4和R5分别为氢、C1-4烷基、可选择取代的苯基或可选择取代的苯基-C1-4烷基，或者R3和R4一起形成化学式-(CH2)3-或-( )4-的烷基链，或者R4和R5与它们连接的碳原子一起形成C3-6环烷基团， R6为C1-4烷基、C1-4烷氧基、羧基、羟基、氰基、卤素、三氟甲基、硝基或氨基， 虚线表示可选的双键，和 氟原子连接在6位或7位； 以及它们的盐和酯，与5-HT血清素受体结合，并在中枢神经系统疾病的治疗中有用。
• QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITION
  申请人：Otsubo Kenji

  公开号：US20100130546A1

  公开（公告）日：2010-05-27

  The present invention provides a quinolone compound represented by General Formula (1) or a salt thereof, wherein R 1 represents a hydrogen atom, etc.; R 2 represents a hydrogen atom, etc.; R 3 represents a phenyl group optionally being substituted with one or more substituents, etc.; R 4 represents a halogen atom; R 5 represents a hydrogen atom or halogen atom; R 6 represents a hydrogen atom; and R 7 represents a hydroxyl group, etc. The quinolone compound have a functional improvement effect, which suppresses progression of neurological dysfunction by inhibiting the chronic progression of Parkinson's disease or protecting dopamine neurons from the disease etiology, thereby prolonging the period before first administration begins.

  本发明提供了一种喹诺酮化合物，其由通式（1）或其盐所表示，其中R1表示氢原子等；R2表示氢原子等；R3表示苯基，该苯基可以选择性地被一个或多个取代基取代等；R4表示卤素原子；R5表示氢原子或卤素原子；R6表示氢原子；R7表示羟基等。该喹诺酮化合物具有功能改善效果，通过抑制帕金森病的慢性进展或保护多巴胺神经元免受疾病病因的影响，从而延长首次给药前的期间，抑制神经功能障碍的进展。
• US8269011B2
  申请人：——

  公开号：US8269011B2

  公开（公告）日：2012-09-18
• US8642619B2
  申请人：——

  公开号：US8642619B2

  公开（公告）日：2014-02-04
• US9045464B2
  申请人：——

  公开号：US9045464B2

  公开（公告）日：2015-06-02